Agilent Technologies, Inc. (NYSE:A) Holdings Raised by Cardinal Capital Management

Cardinal Capital Management increased its stake in Agilent Technologies, Inc. (NYSE:A) by 0.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 68,764 shares of the medical research company’s stock after buying an additional 213 shares during the quarter. Agilent Technologies comprises about 1.5% of Cardinal Capital Management’s holdings, making the stock its 19th biggest position. Cardinal Capital Management’s holdings in Agilent Technologies were worth $9,255,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. CKW Financial Group raised its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. raised its position in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in Agilent Technologies in the third quarter worth about $28,000. Ashton Thomas Securities LLC acquired a new stake in Agilent Technologies in the 3rd quarter valued at about $31,000. Finally, Fortitude Family Office LLC boosted its position in shares of Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 95 shares in the last quarter.

Analyst Ratings Changes

Several analysts recently commented on A shares. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. Bank of America cut their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Finally, Wells Fargo & Company cut their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $144.38.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Agilent Technologies Stock Performance

A stock opened at $134.57 on Tuesday. The stock has a market cap of $38.39 billion, a P/E ratio of 30.45, a P/E/G ratio of 4.00 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. The firm has a 50 day simple moving average of $141.53 and a 200 day simple moving average of $139.40. Agilent Technologies, Inc. has a 52 week low of $124.16 and a 52 week high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Agilent Technologies’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.38 earnings per share. Research analysts anticipate that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Tuesday, December 31st. Agilent Technologies’s payout ratio is currently 22.40%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.